AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2023
Aug 14, 2023
32227_dirs_2023-08-14_051f3205-b83b-4bbf-889c-2b520108f186.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-08-10
Reporting Person: Gunn Neil (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-10 | Stock Option (Right to Buy) | $14.82 | A | 8353 | Acquired | 2033-08-10 | Common Stock (8353) | Direct |
| 2023-08-10 | Restricted Stock Unit | $0 | A | 11336 | Acquired | Common Stock (11336) | Direct |
Footnotes
F1: Once vested, the shares of common stock are not subject to expiration.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24